Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by pabalooon May 10, 2020 9:41pm

84 Views

Post# 31010255

RE:RE:RE:RE:RE:RE:CC

Nah-No big deal either way. Let's hope we continue to move upward this week. Technically we should have little resistance to pop back to 2 bucks as it fell very quickly on little volume and should be able to pop back there on equal volume. The fundamentals are better now than when it was 4 bucks. Not sure if there is someone reading here with a better understanding of charts.

Bullboard Posts

Canadian psychedelic stock to supply MDMA to Yale